Schedule of Gain on Deconsolidation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
Nov. 14, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Nov. 15, 2024 |
|
| Carrying Value of the NCI | $ (4,500) | $ (11,800) | ||
| Gain on deconsolidation | $ 39,307 | |||
| Exozymes Inc [Member] | ||||
| Subtotal of quoted closing price of Class A common shares | 40,727 | 3,931 | ||
| Quoted closing price of Class A common shares | $ 10.36 | |||
| Fair value of warrants | $ 1,327 | |||
| Fair value of equity method investment | 42,054 | |||
| Carrying Value of the NCI | (921) | |||
| Carrying value of assets | 4,282 | |||
| Less carrying value of former investment | $ (5,787) | |||
| Carrying value of warrants | (321) | |||
| Gain on deconsolidation | $ 39,307 | |||
| X | ||||||||||
- Definition Carrying value of assets. No definition available.
|
| X | ||||||||||
- Definition Carrying value of warrants. No definition available.
|
| X | ||||||||||
- Definition Less carrying value of former investment. No definition available.
|
| X | ||||||||||
- Definition Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Fair value portion of investments accounted under the equity method. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of investment owned. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Details
|